Literature DB >> 11932988

High risk of malignancy in mosaic variegated aneuploidy syndrome.

Sébastien Jacquemont1, Michelle Bocéno, Jean Marie Rival, Françoise Méchinaud, Albert David.   

Abstract

Fourteen cases of mosaic variegated aneuploidy (MVA) syndrome have been reported in the last 10 years. The phenotype of this rare condition has been quite consistent: severe microcephaly, growth deficiency, mild physical anomalies, and mental retardation. We describe here a young boy in whom MVA syndrome is associated to myelodysplasia with a monosomy 7 bone marrow clone. At the age of 3 years, myelodysplasia progressed to an acute lymphoblastic leukemia, and the patient died soon after. Several syndromes with short stature and severe microcephaly, such as the Seckel and Nijmegen syndromes, comprise hematological findings and chromosome instability. However, chromosome instability was not confirmed in our patient. MVA with hematological findings has not been reported before, but 3 patients of 14 (21%) have developed a malignancy (rhabdomyosarcoma, acute lymphoblastic leukemia, and nephroblastoma). Therefore, we propose that MVA is a condition predisposing to neoplasia. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11932988     DOI: 10.1002/ajmg.10281

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  24 in total

Review 1.  Mechanisms and consequences of aneuploidy and chromosome instability in the aging brain.

Authors:  Grasiella A Andriani; Jan Vijg; Cristina Montagna
Journal:  Mech Ageing Dev       Date:  2016-03-21       Impact factor: 5.432

2.  Chromosomal instability substantiates poor prognosis in patients with diffuse large B-cell lymphoma.

Authors:  Samuel F Bakhoum; Olga V Danilova; Prabhjot Kaur; Norman B Levy; Duane A Compton
Journal:  Clin Cancer Res       Date:  2011-12-15       Impact factor: 12.531

Review 3.  Kinetochores and disease: keeping microtubule dynamics in check!

Authors:  Samuel F Bakhoum; Duane A Compton
Journal:  Curr Opin Cell Biol       Date:  2011-12-21       Impact factor: 8.382

Review 4.  Chromosomal instability and cancer: a complex relationship with therapeutic potential.

Authors:  Samuel F Bakhoum; Duane A Compton
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

5.  Biallelic TRIP13 mutations predispose to Wilms tumor and chromosome missegregation.

Authors:  Shawn Yost; Bas de Wolf; Sandra Hanks; Anna Zachariou; Chiara Marcozzi; Matthew Clarke; Richarda de Voer; Banafsheh Etemad; Esther Uijttewaal; Emma Ramsay; Harriet Wylie; Anna Elliott; Susan Picton; Audrey Smith; Sarah Smithson; Sheila Seal; Elise Ruark; Gunnar Houge; Jonathan Pines; Geert J P L Kops; Nazneen Rahman
Journal:  Nat Genet       Date:  2017-05-29       Impact factor: 38.330

Review 6.  Cell cycle activation and aneuploid neurons in Alzheimer's disease.

Authors:  Thomas Arendt
Journal:  Mol Neurobiol       Date:  2012-04-13       Impact factor: 5.590

Review 7.  When 2+2=5: the origins and fates of aneuploid and tetraploid cells.

Authors:  Randall W King
Journal:  Biochim Biophys Acta       Date:  2008-08-07

8.  Gradual reduction of BUBR1 protein levels results in premature sister-chromatid separation then in aneuploidy.

Authors:  Elodie Bohers; Nasrin Sarafan-Vasseur; Aurélie Drouet; Marianne Paresy; Jean-Baptiste Latouche; Jean-Michel Flaman; Richard Sesboüé; Thierry Frebourg
Journal:  Hum Genet       Date:  2008-10-19       Impact factor: 4.132

Review 9.  The genomically mosaic brain: aneuploidy and more in neural diversity and disease.

Authors:  Diane M Bushman; Jerold Chun
Journal:  Semin Cell Dev Biol       Date:  2013-03-04       Impact factor: 7.727

10.  SIRT2 induces the checkpoint kinase BubR1 to increase lifespan.

Authors:  Brian J North; Michael A Rosenberg; Karthik B Jeganathan; Angela V Hafner; Shaday Michan; Jing Dai; Darren J Baker; Yana Cen; Lindsay E Wu; Anthony A Sauve; Jan M van Deursen; Anthony Rosenzweig; David A Sinclair
Journal:  EMBO J       Date:  2014-05-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.